Imunon, Inc.

1.22 USD
+0.11 (+9.91%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Imunon, Inc. stock is down -12.86% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.16% of the previous 39 June’s closed higher than May.

About Imunon, Inc.

Celsion Corporation focuses on the development and commercialization of DNA-based immunotherapies and vaccines. Its product pipeline includes GEN-1 and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin.